Literature DB >> 16120026

Production and characterization of neutralizing monoclonal antibodies against human metapneumovirus F protein.

Xiaoming Ma1, Rika Endo, Takashi Ebihara, Nobuhisa Ishiguro, Hiroaki Ishiko, Hideaki Kikuta.   

Abstract

Human metapneumovirus (hMPV) F protein promotes fusion of viral and cell membranes, and is thought to be a major antigenic determinant that mediates effective neutralization and protection against hMPV infection. In this paper, the development of two mouse monoclonal antibodies (MAbs) by immunization with hMPVinfected cells is described. Immunofluorescence assay (IFA) using hMPV F protein-expressing cells indicated that two MAbs, designated 1G3 and 9B10, recognized hMPV F protein. Both MAbs were found to be reactive to two groups of hMPV by an IFA using two groups of hMPV-infected cells. The 9B10 mAb had strong neutralizing activity against both groups of hMPV, while the 1G3 MAb had only weak neutralization activity. These results indicate that the hMPV F protein is a major antigenic determinant that mediates extensive cross-lineage neutralization and protection. Production of MAbs to the hMPV F protein is critical for development of diagnostic techniques, vaccine research, and studies on viral pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120026     DOI: 10.1089/hyb.2005.24.201

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  6 in total

1.  Mapping and characterization of the primary and anamnestic H-2(d)-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus.

Authors:  Guillermina A Melendi; Fidel Zavala; Ursula J Buchholz; Guy Boivin; Peter L Collins; Steven R Kleeberger; Fernando P Polack
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.

Authors:  Nancy D Ulbrandt; Hong Ji; Nita K Patel; Jeffrey M Riggs; Yambasu A Brewah; Shannon Ready; Nanci E Donacki; Karyn Folliot; Arnita S Barnes; Kannaki Senthil; Susan Wilson; Mingzhong Chen; Lori Clarke; Mia MacPhail; Jia Li; Robert M Woods; Kathy Coelingh; Jennifer L Reed; Michael P McCarthy; David S Pfarr; Albert D M E Osterhaus; Ron A M Fouchier; Peter A Kiener; JoAnn A Suzich
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 3.  Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.

Authors:  Andrea E González; Margarita K Lay; Evelyn L Jara; Janyra A Espinoza; Roberto S Gómez; Jorge Soto; Claudia A Rivera; Katia Abarca; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Virulence       Date:  2016-12-02       Impact factor: 5.882

4.  Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.

Authors:  Nancy D Ulbrandt; Hong Ji; Nita K Patel; Arnita S Barnes; Susan Wilson; Peter A Kiener; JoAnn Suzich; Michael P McCarthy
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

Review 5.  Prophylactic and therapeutic approaches for human metapneumovirus.

Authors:  Prashant Kumar; Mansi Srivastava
Journal:  Virusdisease       Date:  2018-10-20

6.  Consensus and variations in cell line specificity among human metapneumovirus strains.

Authors:  Naganori Nao; Ko Sato; Junya Yamagishi; Maino Tahara; Yuichiro Nakatsu; Fumio Seki; Hiroshi Katoh; Aiko Ohnuma; Yuta Shirogane; Masahiro Hayashi; Tamio Suzuki; Hideaki Kikuta; Hidekazu Nishimura; Makoto Takeda
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.